X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (211) 211
Publication (59) 59
Book / eBook (33) 33
Book Chapter (8) 8
Dissertation (5) 5
Newspaper Article (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (127) 127
index medicus (108) 108
female (63) 63
male (62) 62
immunology (43) 43
adult (37) 37
middle aged (37) 37
article (36) 36
aged (30) 30
animals (27) 27
analysis (24) 24
allergy (23) 23
care and treatment (23) 23
oncology (23) 23
research (23) 23
treatment outcome (22) 22
mice (20) 20
abridged index medicus (19) 19
cell biology (19) 19
cancer (17) 17
clinical trials (17) 17
eosinophils - immunology (17) 17
medicine & public health (17) 17
medicine, general & internal (17) 17
respiratory system (17) 17
chemotherapy (16) 16
clinical neurology (16) 16
disease (16) 16
tumors (16) 16
allergy and immunology (15) 15
eosinophils (15) 15
eosinophils - metabolism (15) 15
health aspects (15) 15
hematology (15) 15
patients (15) 15
survival (15) 15
adolescent (14) 14
child (14) 14
drug therapy (14) 14
glioblastoma (14) 14
young adult (14) 14
mortality (13) 13
risk factors (13) 13
cells, cultured (12) 12
expression (12) 12
medicine (12) 12
neurosciences (12) 12
proteins (12) 12
temozolomide (12) 12
therapy (12) 12
classification (11) 11
cytokines (11) 11
diagnosis (11) 11
flow cytometry (11) 11
glioma (11) 11
inflammation (11) 11
medical colleges (11) 11
mutation (11) 11
neurology (11) 11
studies (11) 11
medical research (10) 10
time factors (10) 10
aged, 80 and over (9) 9
asthma (9) 9
drug administration schedule (9) 9
infectious diseases (9) 9
leukocytes (9) 9
multidisciplinary sciences (9) 9
physiological aspects (9) 9
prognosis (9) 9
public health (9) 9
retrospective studies (9) 9
biochemistry & molecular biology (8) 8
brain neoplasms - drug therapy (8) 8
brain neoplasms - pathology (8) 8
disease-free survival (8) 8
drug therapy, combination (8) 8
history (8) 8
hypereosinophilic syndrome (8) 8
hypereosinophilic syndromes (8) 8
management (8) 8
prevalence (8) 8
release (8) 8
surgery (8) 8
usage (8) 8
activation (7) 7
age (7) 7
apoptosis (7) 7
biology (7) 7
brain cancer (7) 7
children (7) 7
churg-strauss-syndrome (7) 7
cohort studies (7) 7
deoxyribonucleic acid--dna (7) 7
disease progression (7) 7
diseases (7) 7
dna (7) 7
dna methylation (7) 7
dose-response relationship, drug (7) 7
double-blind method (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Robarts - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
UofT at Scarborough - Stacks (5) 5
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Royal Ontario Museum - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Searching (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Royal Ontario Museum - Rare Book (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
UofT at Mississauga - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2012, Volume 130, Issue 3, pp. 607 - 612.e9
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2009, Volume 124, Issue 6, pp. 1319 - 1325.e3
Background Hypereosinophilic syndrome (HES) is a heterogeneous group of rare disorders defined by persistent blood eosinophilia ≥1.5 × 109 /L, absence of a... 
Allergy and Immunology | hypereosinophilic syndrome | Eosinophil | FIP1L1-PDGFRA | MEPOLIZUMAB | FUSION | IDIOPATHIC EOSINOPHILIA | ALLERGY | LYMPHOCYTIC VARIANT | IMATINIB | PREVALENCE | IMMUNOLOGY | Hypereosinophilic Syndrome - drug therapy | Piperazines - administration & dosage | Eosinophils - metabolism | Oncogene Proteins, Fusion - metabolism | Eosinophils - drug effects | Tryptases - blood | mRNA Cleavage and Polyadenylation Factors - metabolism | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | mRNA Cleavage and Polyadenylation Factors - immunology | Adrenal Cortex Hormones - therapeutic use | Eosinophils - immunology | Oncogene Proteins, Fusion - immunology | Young Adult | Antibodies, Monoclonal, Humanized | Receptor, Platelet-Derived Growth Factor alpha - immunology | Aged, 80 and over | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Child | Hypereosinophilic Syndrome - metabolism | Chemokine CCL17 - blood | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Pyrimidines - administration & dosage | Interferon-alpha - therapeutic use | Hydroxyurea - administration & dosage | Piperazines - therapeutic use | Imatinib Mesylate | Interleukin-5 - blood | Interferon-alpha - administration & dosage | Cyclosporine - therapeutic use | Antibodies, Monoclonal - administration & dosage | Pyrimidines - therapeutic use | Adolescent | Cyclosporine - administration & dosage | Hydroxyurea - therapeutic use | Aged | Benzamides | Hypereosinophilic Syndrome - immunology | Adrenal Cortex Hormones - administration & dosage | Medical personnel | Medical colleges | Allergy | Malpractice | Leukemia | Physicians (General practice) | T cells | Allergic reaction | Growth factors | Flow cytometry | Parasitic diseases | Colleges & universities | Ligands | Drug therapy | Light therapy | Chemokines | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 682 - 694
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2016, Volume 4, Issue 11, pp. 882 - 893
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article